Matulay JT - Search Results

1

Clinical and Genomic Considerations for Variant Histology in Bladder Cancer.

Matulay JT, Narayan VM, Kamat AM. Matulay JT, et al. Curr Oncol Rep. 2019 Feb 26;21(3):23. doi: 10.1007/s11912-019-0772-8. Curr Oncol Rep. 2019. PMID: 30806832 Review.

2

Advances in risk stratification of bladder cancer to guide personalized medicine.

Matulay JT, Kamat AM. Matulay JT, et al. F1000Res. 2018 Jul 25;7:F1000 Faculty Rev-1137. doi: 10.12688/f1000research.14903.1. eCollection 2018. F1000Res. 2018. PMID: 30109022 Free PMC article. Review.

3

The impact of squamous histology on survival in patients with muscle-invasive bladder cancer.

Matulay JT, Woldu SL, Lim A, Narayan VM, Li G, Kamat AM, Anderson CB. Matulay JT, et al. Urol Oncol. 2019 Jun;37(6):353.e17-353.e24. doi: 10.1016/j.urolonc.2019.01.020. Epub 2019 Jan 28. Urol Oncol. 2019. PMID: 30704959

4

A Case for Risk-adapted Management of Low-grade Bladder Tumors.

Soloway M, Matulay JT, Kamat AM. Soloway M, et al. Among authors: matulay jt. Eur Urol Oncol. 2020 Feb;3(1):128-129. doi: 10.1016/j.euo.2019.09.007. Epub 2019 Oct 20. Eur Urol Oncol. 2020. PMID: 31645295

5

Risk-adapted management of low-grade bladder tumours: recommendations from the International Bladder Cancer Group (IBCG).

Matulay JT, Soloway M, Witjes JA, Buckley R, Persad R, Lamm DL, Boehle A, Palou J, Colombel M, Brausi M, Kamat AM. Matulay JT, et al. BJU Int. 2020 Apr;125(4):497-505. doi: 10.1111/bju.14995. Epub 2020 Feb 8. BJU Int. 2020. PMID: 31950596 Review.

6

Radical cystectomy in women: Impact of the robot-assisted versus open approach on surgical outcomes.

Narayan VM, Seif MA, Lim AH, Li R, Matulay JT, Kukreja JB, Qiao W, Hwang H, Shah JB, Pisters L, Kamat AM, Dinney C, Navai N. Narayan VM, et al. Among authors: matulay jt. Urol Oncol. 2020 Apr;38(4):247-254. doi: 10.1016/j.urolonc.2019.12.005. Epub 2020 Jan 14. Urol Oncol. 2020. PMID: 31953001

7

Variability in adherence to guidelines based management of nonmuscle invasive bladder cancer among Society of Urologic Oncology (SUO) members.

Matulay JT, Tabayoyong W, Duplisea JJ, Chang C, Daneshmand S, Gore JL, Holzbeierlein JM, Karsh LI, Kim SP, Konety BR, Li R, McKiernan JM, Messing EM, Steinberg GD, Williams SB, Kamat AM. Matulay JT, et al. Urol Oncol. 2020 Oct;38(10):796.e1-796.e6. doi: 10.1016/j.urolonc.2020.04.026. Epub 2020 May 17. Urol Oncol. 2020. PMID: 32430255

8

Bacillus Calmette-Guérin Retains Clinically Relevant Viability for up to 72 Hours After Reconstitution: Potential Implications for Clinical Practice in Times of Shortage.

Brooks N, Nagaraju S, Matulay J, Han XY, Kamat AM. Brooks N, et al. Eur Urol Oncol. 2021 Oct;4(5):826-828. doi: 10.1016/j.euo.2020.03.004. Epub 2020 May 29. Eur Urol Oncol. 2021. PMID: 32475716

9

The obesity paradox: defining the impact of body mass index and diabetes mellitus for patients with non-muscle-invasive bladder cancer treated with bacillus Calmette-Guérin.

Brooks NA, Kokorovic A, Xiao L, Matulay JT, Li R, Ranasinghe WKB, Nagaraju S, Shen Y, Gao J, Navai N, Dinney CPN, Grossman HB, Kamat AM. Brooks NA, et al. Among authors: matulay jt. BJU Int. 2021 Jul;128(1):65-71. doi: 10.1111/bju.15296. Epub 2020 Dec 5. BJU Int. 2021. PMID: 33210440

10

Impact of upper tract urothelial carcinoma on response to BCG in patients with non-muscle-invasive bladder cancer.

Bree KK, Hensley PJ, Brooks NA, Matulay J, Li R, Nogueras Gonzalez GM, Navai N, Grossman HB, Matin SF, Dinney CPN, Kamat AM. Bree KK, et al. BJU Int. 2021 Nov;128(5):568-574. doi: 10.1111/bju.15344. Epub 2021 Feb 15. BJU Int. 2021. PMID: 33484074

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

56 results

Search Page

Filters